Excisional treatment in women with cervical adenocarcinoma in situ (AIS): a prospective randomised controlled non-inferiority trial to compare AIS persistence/recurrence after loop electrosurgical excision procedure with cold knife cone biopsy: protocol for a pilot study
Paul A. Cohen(The University of Western Australia), Pennie Stoyles(Australia New Zealand Gynaecological Oncology Group), Lois Eva(University of Auckland), Peter Sykes(Christchurch Hospital), Max Bulsara(The University of Notre Dame Australia), Archana Rao(Royal Hospital for Women), Martin R. Stockler, Jim Codde(The University of Notre Dame Australia), Alison H. Brand(The University of Sydney), C. David Wrede(Royal Women's Hospital), Yee Leung(King Edward Memorial Hospital), Lyndal Anderson(The University of Sydney), Orla McNally(Royal Women's Hospital), Michael J. Campion(Royal Hospital for Women), Aime Powell(St John of God Subiaco Hospital), Louise Farrell(King Edward Memorial Hospital)
Cited by 5
Related Papers
Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: a Canadian randomized trial with palliative end points.
|Journal of Clinical Oncology|1996|1.6k
The quanitification of drug caused morbidity and mortality in Australia: Part 1
|UWA Profiles and Research Repository (University of Western Australia)|1995|470
Poor Long-Term Survival in Patients With Moderate Aortic Stenosis
|Journal of the American College of Cardiology|2019|418
Methylation of all BRCA1 copies predicts response to the PARP inhibitor rucaparib in ovarian carcinoma
|Nature Communications|2018|299